Topical reinforcement of the cervical mucus barrier to sperm

• Published in: Science translational medicine Vol. 14; no. 673; p. eabm2417
• Main Authors: Schimpf, Ulrike, Caldas-Silveira, Erika, Katchan, Ljudmila, Vigier-Carriere, Cécile, Lantier, Isabelle, Nachmann, Gilai, Gidlöf, Sebastian, Jonasson, Aino Fianu, Björndahl, Lars, Trombotto, Stéphane, Druart, Xavier, Crouzier, Thomas
• Format: Journal Article
• Language: English
• Published: United States 2022
• Subjects: Animals; Cervix Mucus; Chitosan; Contraceptive Agents; Female; Humans; Male; Pregnancy; Semen; Sheep; Sperm Motility; Spermatozoa
• ISSN: 1946-6242
• DOI: 10.1126/scitranslmed.abm2417

Close to half of the world's pregnancies are still unplanned, reflecting a clear unmet need in contraception. Ideally, a contraceptive would provide the high efficacy of hormonal treatments, without systemic side effects. Here, we studied topical reinforcement of the cervical mucus by chitosan mucoadhesive polymers as a form of female contraceptive. Chitosans larger than 7 kDa effectively cross-linked human ovulatory cervical mucus to prevent sperm penetration in vitro. We then demonstrated in vivo using the ewe as a model that vaginal gels containing chitosan could stop ram sperm at the entrance of the cervical canal and prevent them from reaching the uterus, whereas the same gels without chitosan did not substantially limit sperm migration. Chitosan did not affect sperm motility in vitro or in vivo, suggesting reinforcement of the mucus physical barrier as the primary mechanism of action. The chitosan formulations did not damage or irritate the ewe vaginal epithelium, in contrast to nonoxynol-9 spermicide. The demonstration that cervical mucus can be reinforced topically to create an effective barrier to sperm may therefore form the technological basis for muco-cervical barrier contraceptives with the potential to become an alternative to hormonal contraceptives.